Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 1416 entries
Sorted by: Best Match Show Resources per page
Periodontal disease and late-onset aortic prosthetic vascular graft infection.

Case reports in vascular medicine

Thomas S, Ghosh J, Porter J, Cockcroft A, Rautemaa-Richardson R.
PMID: 25685592
Case Rep Vasc Med. 2015;2015:768935. doi: 10.1155/2015/768935. Epub 2015 Jan 21.

Prosthetic vascular graft infection (PVGI) is a rare but significant complication of arterial reconstructive surgery. Although the relative risk is low, the clinical consequences can be catastrophic. Microbiological data on causative bacteria are limited. We present four cases of...

Cite
Thomas S, Ghosh J, Porter J, et al. Periodontal disease and late-onset aortic prosthetic vascular graft infection. Case Rep Vasc Med. 2015;2015:768935doi: 10.1155/2015/768935.
Thomas, S., Ghosh, J., Porter, J., Cockcroft, A., & Rautemaa-Richardson, R. (2015). Periodontal disease and late-onset aortic prosthetic vascular graft infection. Case reports in vascular medicine, 2015768935. https://doi.org/10.1155/2015/768935
Thomas, Stephanie, et al. "Periodontal disease and late-onset aortic prosthetic vascular graft infection." Case reports in vascular medicine vol. 2015 (2015): 768935. doi: https://doi.org/10.1155/2015/768935
Thomas S, Ghosh J, Porter J, Cockcroft A, Rautemaa-Richardson R. Periodontal disease and late-onset aortic prosthetic vascular graft infection. Case Rep Vasc Med. 2015;2015:768935. doi: 10.1155/2015/768935. Epub 2015 Jan 21. PMID: 25685592; PMCID: PMC4320805.
Copy Download .nbib Format: NLM
Critical behavior of subcellular density organization during neutrophil activation and migration.

Cellular and molecular bioengineering

Baker-Groberg SM, Phillips KG, Healy LD, Itakura A, Porter JE, Newton PK, Nan X, McCarty OJ.
PMID: 26640599
Cell Mol Bioeng. 2015 Dec 01;8(4):543-552. doi: 10.1007/s12195-015-0400-0. Epub 2015 Jun 03.

Physical theories of active matter continue to provide a quantitative understanding of dynamic cellular phenomena, including cell locomotion. Although various investigations of the rheology of cells have identified important viscoelastic and traction force parameters for use in these theoretical...

Cite
Baker-Groberg SM, Phillips KG, Healy LD, et al. Critical behavior of subcellular density organization during neutrophil activation and migration. Cell Mol Bioeng. 2015;8(4):543-552doi: 10.1007/s12195-015-0400-0.
Baker-Groberg, S. M., Phillips, K. G., Healy, L. D., Itakura, A., Porter, J. E., Newton, P. K., Nan, X., & McCarty, O. J. (2015). Critical behavior of subcellular density organization during neutrophil activation and migration. Cellular and molecular bioengineering, 8(4), 543-552. https://doi.org/10.1007/s12195-015-0400-0
Baker-Groberg, Sandra M, et al. "Critical behavior of subcellular density organization during neutrophil activation and migration." Cellular and molecular bioengineering vol. 8,4 (2015): 543-552. doi: https://doi.org/10.1007/s12195-015-0400-0
Baker-Groberg SM, Phillips KG, Healy LD, Itakura A, Porter JE, Newton PK, Nan X, McCarty OJ. Critical behavior of subcellular density organization during neutrophil activation and migration. Cell Mol Bioeng. 2015 Dec 01;8(4):543-552. doi: 10.1007/s12195-015-0400-0. Epub 2015 Jun 03. PMID: 26640599; PMCID: PMC4667984.
Copy Download .nbib Format: NLM
Pathologic Response Rates of Gemcitabine/Cisplatin versus Methotrexate/Vinblastine/Adriamycin/Cisplatin Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Bladder Cancer.

Advances in urology

Lee FC, Harris W, Cheng HH, Shenoi J, Zhao S, Wang J, Champion T, Izard J, Gore JL, Porter M, Yu EY, Wright JL.
PMID: 24382958
Adv Urol. 2013;2013:317190. doi: 10.1155/2013/317190. Epub 2013 Dec 08.

Objectives. To compare pathologic outcomes after treatment with gemcitabine and cisplatin (GC) versus methotrexate, vinblastine, adriamycin, and cisplatin (MVAC) in the neoadjuvant setting. Methods. Data was retrospectively collected on 178 patients with T2-T4 bladder cancer who underwent radical cystectomy...

Cite
Lee FC, Harris W, Cheng HH, et al. Pathologic Response Rates of Gemcitabine/Cisplatin versus Methotrexate/Vinblastine/Adriamycin/Cisplatin Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Bladder Cancer. Adv Urol. 2013;2013:317190doi: 10.1155/2013/317190.
Lee, F. C., Harris, W., Cheng, H. H., Shenoi, J., Zhao, S., Wang, J., Champion, T., Izard, J., Gore, J. L., Porter, M., Yu, E. Y., & Wright, J. L. (2013). Pathologic Response Rates of Gemcitabine/Cisplatin versus Methotrexate/Vinblastine/Adriamycin/Cisplatin Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Bladder Cancer. Advances in urology, 2013317190. https://doi.org/10.1155/2013/317190
Lee, Franklin C, et al. "Pathologic Response Rates of Gemcitabine/Cisplatin versus Methotrexate/Vinblastine/Adriamycin/Cisplatin Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Bladder Cancer." Advances in urology vol. 2013 (2013): 317190. doi: https://doi.org/10.1155/2013/317190
Lee FC, Harris W, Cheng HH, Shenoi J, Zhao S, Wang J, Champion T, Izard J, Gore JL, Porter M, Yu EY, Wright JL. Pathologic Response Rates of Gemcitabine/Cisplatin versus Methotrexate/Vinblastine/Adriamycin/Cisplatin Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Bladder Cancer. Adv Urol. 2013;2013:317190. doi: 10.1155/2013/317190. Epub 2013 Dec 08. PMID: 24382958; PMCID: PMC3871504.
Copy Download .nbib Format: NLM
Tailoring 10 nm scale suspended graphene junctions and quantum dots.

Nano letters

Tayari V, McRae AC, Yiğen S, Island JO, Porter JM, Champagne AR.
PMID: 25490053
Nano Lett. 2015 Jan 14;15(1):114-9. doi: 10.1021/nl503151g. Epub 2014 Dec 11.

The possibility to make 10 nm scale, and low-disorder, suspended graphene devices would open up many possibilities to study and make use of strongly coupled quantum electronics, quantum mechanics, and optics. We present a versatile method, based on the...

Cite
Tayari V, McRae AC, Yiğen S, et al. Tailoring 10 nm scale suspended graphene junctions and quantum dots. Nano Lett. 2014;15(1):114-9doi: 10.1021/nl503151g.
Tayari, V., McRae, A. C., Yiğen, S., Island, J. O., Porter, J. M., & Champagne, A. R. (2015). Tailoring 10 nm scale suspended graphene junctions and quantum dots. Nano letters, 15(1), 114-9. https://doi.org/10.1021/nl503151g
Tayari, Vahid, et al. "Tailoring 10 nm scale suspended graphene junctions and quantum dots." Nano letters vol. 15,1 (2015): 114-9. doi: https://doi.org/10.1021/nl503151g
Tayari V, McRae AC, Yiğen S, Island JO, Porter JM, Champagne AR. Tailoring 10 nm scale suspended graphene junctions and quantum dots. Nano Lett. 2015 Jan 14;15(1):114-9. doi: 10.1021/nl503151g. Epub 2014 Dec 11. PMID: 25490053.
Copy Download .nbib Format: NLM
A population-based study of the epidemiology of pancreatic cancer: a brief report.

Current oncology (Toronto, Ont.)

Raju RS, Coburn N, Liu N, Porter JM, Seung SJ, Cheung MC, Goyert N, Leighl NB, Hoch JS, Trudeau ME, Evans WK, Dainty KN, Earle CC, Mittmann N.
PMID: 26715886
Curr Oncol. 2015 Dec;22(6):e478-84. doi: 10.3747/co.22.2653.

OBJECTIVE: Administrative data are used to describe the pancreatic cancer (pcc) population. The analysis examines demographic details, incidence, site, survival, and factors influencing mortality in a cohort of individuals diagnosed with pcc.METHODS: Incident cases of pcc diagnosed in Ontario...

Cite
Raju RS, Coburn N, Liu N, et al. A population-based study of the epidemiology of pancreatic cancer: a brief report. Curr Oncol. 2015;22(6):e478-84doi: 10.3747/co.22.2653.
Raju, R. S., Coburn, N., Liu, N., Porter, J. M., Seung, S. J., Cheung, M. C., Goyert, N., Leighl, N. B., Hoch, J. S., Trudeau, M. E., Evans, W. K., Dainty, K. N., Earle, C. C., & Mittmann, N. (2015). A population-based study of the epidemiology of pancreatic cancer: a brief report. Current oncology (Toronto, Ont.), 22(6), e478-84. https://doi.org/10.3747/co.22.2653
Raju, R S, et al. "A population-based study of the epidemiology of pancreatic cancer: a brief report." Current oncology (Toronto, Ont.) vol. 22,6 (2015): e478-84. doi: https://doi.org/10.3747/co.22.2653
Raju RS, Coburn N, Liu N, Porter JM, Seung SJ, Cheung MC, Goyert N, Leighl NB, Hoch JS, Trudeau ME, Evans WK, Dainty KN, Earle CC, Mittmann N. A population-based study of the epidemiology of pancreatic cancer: a brief report. Curr Oncol. 2015 Dec;22(6):e478-84. doi: 10.3747/co.22.2653. PMID: 26715886; PMCID: PMC4687674.
Copy Download .nbib Format: NLM
Therapeutic Potential of Shark Anti-ICOSL VNAR Domains is Exemplified in a Murine Model of Autoimmune Non-Infectious Uveitis.

Frontiers in immunology

Kovaleva M, Johnson K, Steven J, Barelle CJ, Porter A.
PMID: 28993766
Front Immunol. 2017 Sep 25;8:1121. doi: 10.3389/fimmu.2017.01121. eCollection 2017.

Induced costimulatory ligand (ICOSL) plays an important role in the activation of T cells through its interaction with the inducible costimulator, ICOS. Suppression of full T cell activation can be achieved by blocking this interaction and has been shown...

Cite
Kovaleva M, Johnson K, Steven J, et al. Therapeutic Potential of Shark Anti-ICOSL VNAR Domains is Exemplified in a Murine Model of Autoimmune Non-Infectious Uveitis. Front Immunol. 2017;8:1121doi: 10.3389/fimmu.2017.01121.
Kovaleva, M., Johnson, K., Steven, J., Barelle, C. J., & Porter, A. (2017). Therapeutic Potential of Shark Anti-ICOSL VNAR Domains is Exemplified in a Murine Model of Autoimmune Non-Infectious Uveitis. Frontiers in immunology, 81121. https://doi.org/10.3389/fimmu.2017.01121
Kovaleva, Marina, et al. "Therapeutic Potential of Shark Anti-ICOSL VNAR Domains is Exemplified in a Murine Model of Autoimmune Non-Infectious Uveitis." Frontiers in immunology vol. 8 (2017): 1121. doi: https://doi.org/10.3389/fimmu.2017.01121
Kovaleva M, Johnson K, Steven J, Barelle CJ, Porter A. Therapeutic Potential of Shark Anti-ICOSL VNAR Domains is Exemplified in a Murine Model of Autoimmune Non-Infectious Uveitis. Front Immunol. 2017 Sep 25;8:1121. doi: 10.3389/fimmu.2017.01121. eCollection 2017. PMID: 28993766; PMCID: PMC5622306.
Copy Download .nbib Format: NLM
Notes on Pathology.

The Indian medical gazette

Porter A.
PMID: 28997994
Ind Med Gaz. 1877 Jun 01;12(6):144-146.

No abstract available.

Cite
Porter A. Notes on Pathology. Ind Med Gaz. 1877;12(6):144-146
Porter, A. (1877). Notes on Pathology. The Indian medical gazette, 12(6), 144-146.
Porter, A. "Notes on Pathology." The Indian medical gazette vol. 12,6 (1877): 144-146.
Porter A. Notes on Pathology. Ind Med Gaz. 1877 Jun 01;12(6):144-146. PMID: 28997994; PMCID: PMC5139170.
Copy Download .nbib Format: NLM
Scorpion-Sting: Death in 12 Hours.

The Indian medical gazette

Porter A.
PMID: 28998002
Ind Med Gaz. 1877 Aug 01;12(8):208-209.

No abstract available.

Cite
Porter A. Scorpion-Sting: Death in 12 Hours. Ind Med Gaz. 1877;12(8):208-209
Porter, A. (1877). Scorpion-Sting: Death in 12 Hours. The Indian medical gazette, 12(8), 208-209.
Porter, A. "Scorpion-Sting: Death in 12 Hours." The Indian medical gazette vol. 12,8 (1877): 208-209.
Porter A. Scorpion-Sting: Death in 12 Hours. Ind Med Gaz. 1877 Aug 01;12(8):208-209. PMID: 28998002; PMCID: PMC5139178.
Copy Download .nbib Format: NLM
Notes on Pathology.

The Indian medical gazette

Porter A.
PMID: 28998011
Ind Med Gaz. 1877 Aug 01;12(8):201-204.

No abstract available.

Cite
Porter A. Notes on Pathology. Ind Med Gaz. 1877;12(8):201-204
Porter, A. (1877). Notes on Pathology. The Indian medical gazette, 12(8), 201-204.
Porter, A. "Notes on Pathology." The Indian medical gazette vol. 12,8 (1877): 201-204.
Porter A. Notes on Pathology. Ind Med Gaz. 1877 Aug 01;12(8):201-204. PMID: 28998011; PMCID: PMC5139187.
Copy Download .nbib Format: NLM
Notes on Pathology.

The Indian medical gazette

Porter A.
PMID: 28998020
Ind Med Gaz. 1877 Jul 02;12(7):175-178.

No abstract available.

Cite
Porter A. Notes on Pathology. Ind Med Gaz. 1877;12(7):175-178
Porter, A. (1877). Notes on Pathology. The Indian medical gazette, 12(7), 175-178.
Porter, A. "Notes on Pathology." The Indian medical gazette vol. 12,7 (1877): 175-178.
Porter A. Notes on Pathology. Ind Med Gaz. 1877 Jul 02;12(7):175-178. PMID: 28998020; PMCID: PMC5139200.
Copy Download .nbib Format: NLM
Giant electron-hole transport asymmetry in ultra-short quantum transistors.

Nature communications

McRae AC, Tayari V, Porter JM, Champagne AR.
PMID: 28561024
Nat Commun. 2017 May 31;8:15491. doi: 10.1038/ncomms15491.

Making use of bipolar transport in single-wall carbon nanotube quantum transistors would permit a single device to operate as both a quantum dot and a ballistic conductor or as two quantum dots with different charging energies. Here we report...

Cite
McRae AC, Tayari V, Porter JM, et al. Giant electron-hole transport asymmetry in ultra-short quantum transistors. Nat Commun. 2017;8:15491doi: 10.1038/ncomms15491.
McRae, A. C., Tayari, V., Porter, J. M., & Champagne, A. R. (2017). Giant electron-hole transport asymmetry in ultra-short quantum transistors. Nature communications, 815491. https://doi.org/10.1038/ncomms15491
McRae, A C, et al. "Giant electron-hole transport asymmetry in ultra-short quantum transistors." Nature communications vol. 8 (2017): 15491. doi: https://doi.org/10.1038/ncomms15491
McRae AC, Tayari V, Porter JM, Champagne AR. Giant electron-hole transport asymmetry in ultra-short quantum transistors. Nat Commun. 2017 May 31;8:15491. doi: 10.1038/ncomms15491. PMID: 28561024; PMCID: PMC5460015.
Copy Download .nbib Format: NLM
Corrigendum: SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice.

Nature chemical biology

Palacino J, Swalley SE, Song C, Cheung AK, Shu L, Zhang X, Van Hoosear M, Shin Y, Chin DN, Keller CG, Beibel M, Renaud NA, Smith TM, Salcius M, Shi X, Hild M, Servais R, Jain M, Deng L, Bullock C, McLellan M, Schuierer S, Murphy L, Blommers MJ, Blaustein C, Berenshteyn F, Lacoste A, Thomas JR, Roma G, Michaud GA, Tseng BS, Porter JA, Myer VE, Tallarico JA, Hamann LG, Curtis D, Fishman MC, Dietrich WF, Dales NA, Sivasankaran R.
PMID: 26991088
Nat Chem Biol. 2016 Apr;12(4):304. doi: 10.1038/nchembio0416-304c.

No abstract available.

Cite
Palacino J, Swalley SE, Song C, et al. Corrigendum: SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice. Nat Chem Biol. 2016;12(4):304doi: 10.1038/nchembio0416-304c.
Palacino, J., Swalley, S. E., Song, C., Cheung, A. K., Shu, L., Zhang, X., Van Hoosear, M., Shin, Y., Chin, D. N., Keller, C. G., Beibel, M., Renaud, N. A., Smith, T. M., Salcius, M., Shi, X., Hild, M., Servais, R., Jain, M., Deng, L., Bullock, C., McLellan, M., Schuierer, S., Murphy, L., Blommers, M. J., Blaustein, C., Berenshteyn, F., Lacoste, A., Thomas, J. R., Roma, G., Michaud, G. A., Tseng, B. S., Porter, J. A., Myer, V. E., Tallarico, J. A., Hamann, L. G., Curtis, D., Fishman, M. C., Dietrich, W. F., Dales, N. A., & Sivasankaran, R. (2016). Corrigendum: SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice. Nature chemical biology, 12(4), 304. https://doi.org/10.1038/nchembio0416-304c
Palacino, James, et al. "Corrigendum: SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice." Nature chemical biology vol. 12,4 (2016): 304. doi: https://doi.org/10.1038/nchembio0416-304c
Palacino J, Swalley SE, Song C, Cheung AK, Shu L, Zhang X, Van Hoosear M, Shin Y, Chin DN, Keller CG, Beibel M, Renaud NA, Smith TM, Salcius M, Shi X, Hild M, Servais R, Jain M, Deng L, Bullock C, McLellan M, Schuierer S, Murphy L, Blommers MJ, Blaustein C, Berenshteyn F, Lacoste A, Thomas JR, Roma G, Michaud GA, Tseng BS, Porter JA, Myer VE, Tallarico JA, Hamann LG, Curtis D, Fishman MC, Dietrich WF, Dales NA, Sivasankaran R. Corrigendum: SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice. Nat Chem Biol. 2016 Apr;12(4):304. doi: 10.1038/nchembio0416-304c. PMID: 26991088.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 1416 entries